$MDGL news
The latest MDGL stock news: headlines, filings, AI summaries and sentiment for $MDGL, updated around the clock.
- Madrigal Pharmaceuticals Announces Q3 Sales Growth and Updates Clinical Trial Timelines
- Madrigal Pharmaceuticals Achieves First Profitable Quarter Driven by Rezdiffra Sales Growth
- MADRIGAL PHARMACEUTICALS, INC. - 10-Q Filing
- MADRIGAL PHARMACEUTICALS, INC. - 8-K Filing
- Institutional Investors Are Increasing Their Stake in Madrigal Pharmaceuticals
- MADRIGAL PHARMACEUTICALS, INC. - 8-K Filing
- BofA Lowers Price Target for Madrigal Pharmaceuticals (MDGL)
- Madrigal Pharmaceuticals Reports Strong Q1 2026 Performance with Rezdiffra's Blockbuster Sales
- Madrigal (MDGL) Reports Q1 2026 Earnings with Strong Growth in Rezdiffra Sales